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Abstract 
Background: the serum markers of myocardial injury are used to help in establishing the diagnosis 
of myocardial infarction. 
Objective: to measure the levels of xanthine oxidase activity and malondialdehyde in myocardial 
infarction patients. 
Methods: 100 patients with myocardial infarction and 50 healthy persons were included in this 
study. Xanthine oxidase activity assayed according to the method described by bergmeyer, h.u. 
while malondialdehyde (MDA) estimation was carried by thiobarbituric acid (TBA) based 
colorimetric method. 
Results: significant increasing levels of xanthine oxidase activity and malondialdehyde were found 
in the blood of the patients with myocardial infarction when compared to healthy persons. 
Conclusions: we propose the measurement of the blood levels of xanthine oxidase as a marker of 
myocardial infarction. 
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yocardial ischemia results from the 
reduction of coronary flow to such 
an extent that supply of oxygen to 
the myocardium does not meet the oxygen 
demand of myocardial tissue. When this 
ischemia is prolonged and irreversible then 
myocardial cell death and necrosis occurs 
which is defined as myocardial infarction 
(MI). ECG is the most widely used method 
for the diagnosis of myocardial infarction, but 
many times ECG shows inconclusive pattern1. 
Estimation of serum biochemical markers of 
myocardial injury arises to confirm the 
diagnosis of myocardial injury. 
The older markers like aspartate amino-
transferase, creatine kinase, lactate 
dehydrogenase etc. lost their utility due to 
lack of specificity and limited sensitivities2. 
However, among the currently available 
markers the troponin test appears to be the 
most promising as far as its sensitivity, 
specificity, turnaround time and cost is 
concerned. Nevertheless, there are reports to 
show  that  abnormal  levels  of  troponin   are 
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found in various conditions which are not 
related to acute coronary diseases2, 3. It is 
clear from the foregoing review that none of 
the markers available so far meet all the 
criteria required for an ideal biochemical 
marker of myocardial injury.  
Oxygen free radical generation has been 
shown to be an important mechanism of 
cellular injury in ischemic myocardium4. 
Several mechanisms have been proposed to 
be involved in the generation of oxygen free 
radicals. Xanthine oxidase has been shown to 
be a major source of free radical generation 
under ischemic conditions5. 
Xanthine oxidase (XO) is an enzyme that 
catalyzes the chain reactions of hypoxanthine 
oxidizing to xanthine and xanthine oxidizing 
to uric acid and hydrogen peroxide. Oxidation 
requires the addition of oxygen and water. 
This process is important because it explains 
how humans are able to metabolize purines6. 
Under ischemic conditions, there is depletion 
of ATP and subsequent loss of membrane 
Ca2+ gradient. Increased Ca2+ levels activate 
Ca2+ dependent proteases which are converted 
into xanthine oxidase7. Thus xanthine oxidase 
in ischemic conditions of the heart may play 
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an important role in generating free radical 
mediated damage1.  
Malondialdehyde (MDA) is a highly reactive 
three carbon dialdehyde produced as a 
byproduct of polyunsaturated fatty acid 
peroxidation and arachidonic acid 
metabolism. MDA readily combines with 
several functional groups on molecules 
including proteins, lipoproteins, and DNA8. 
Polyunsaturated fatty acid peroxides further 
react to form MDA. MDA can be found in 
most biological samples as a result of lipid 
peroxidation5.  
In this study, the levels of xanthine oxidase 
and MDA were measured in MI patients and 
compared with healthy persons as control. 
Study protocols were approved by the Al-
Shaab Teaching Hospital ethics committee.  
Materials and Methods 
10 ml venous blood specimens were collected 
in EDTA vacutainer from 100 patients with 
acute myocardial infarction who were 
attending the Sudanese Armed Forces 
Hospital, the Cardiac Centre of Ahmed 
Quasim Hospital, and Al-Shaab Teaching 
Hospital. Clinical examination of all patients 
was done to detect any co-existing disorder. 
Cases with known organic disorders were 
excluded from the study. 
50 healthy volunteers -age and sex matched- 
served as control group. Both healthy and 
patient groups comprised of non-smokers and 
within the age group of 40-65 years. Informed 
consent was taken from each patient and 
healthy person employed in the study. 
Assay of Xanthine Oxidase Activity:9 
Principle of the xanthine oxidase method:  
Xanthine + O2 +H2O  
xan t h in e  ox id as e   Uric 
acid + H2O2 
The rate of formation of uric acid is 
determined by measuring increased 
absorbance at 290 nm.  
A unit of activity is that forming one 
micromole of uric acid/minute. 
Reagents 
Solution (A) = Tris-HCl buffer, pH 7.5: 0.1M 
Solution (B) = Xanthine solution: 10mM 
Solution (C) = Oxonic acid potassium salt 
solution: 1mM 
Solution (D) = Enzyme diluent: 50mM 
The buffer mixture was prepared by adding 
2.24ml from solution (A) to 0.08ml from 
solution (C) and 0.08ml from solution (D) in 
a test tube and was incubated at 37ºC for 
about 5 minutes. 
Procedure: 
Into the test tube of the cuvettes  1.9 ml of the 
buffer mixture above were added to 0.1ml of 
sample and 1.0 ml of solution B while in the 
control tube 1.9 ml of the buffer mixture, 
0.1ml of sample and 1.0 ml of distilled water  
were pipetted. The increase in optical density 
(OD) at 290 nm against water for three 
minutes in a spectrophotometer (Camspec. 
UV/VIS, UK) was recorded, and the OD per 
minute was calculated. 
 
Assay of malondialdehyde (MDA) 
estimation: 
The method is Thiobarbituric acid (TBA) 
based colorimetric. Assay is based on the 
reaction of MDA with TBA forming a MDA-
TBA2 adducts that absorbs strongly at        
532 nm10.  
In test tube mix the following: Plasma (0.2 
ml), 8.1% sodium dodecyl sulphate (0.8 ml), 
Glacial acetic acid (0.5 ml) and 0.8% 
thiobarbituric acid (1.5 ml). 
Contents of the tubes were mixed and heated 
over water bath maintained at 90°C for one 
hour and immediately cooled thereafter under 
running water. Then in each test tube add 1.0 
ml of distilled water and 5.0 ml of n-butanol 
and pyridine (15:1 v/v). Then contents of test 
tubes were mixed and centrifuged at 8000 
rpm for ten minutes. The upper layer was 
aspirated out and color intensity was 
measured at 532 nm colorimetry (Roche 
Integra 700).  
Statistical analysis were carried out using 
Student’s‘t’ test by statistical packages for 
social science software (SPSS).Values of 





As shown in table 1&2, specific activity of 
xanthine oxidase increases in the blood of 
patients with myocardial infarction when 
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compared to healthy persons (p<0.05), 
malondialdehyde (MDA) levels are also 
statistically significantly increased in the 
blood of patients with myocardial infarction 
when compared to healthy controls (p<0.05). 
Table (1): Xanthine oxidase level in the blood 














Table (2): MDA level in the blood of MI 















Table 3 showed that the sensitivity of 
xanthine oxidase (XO) and malondialdehyde 
(MDA) was 100% and 88% respectively in 
patients with myocardial infarction (MI) and 
it was 0% in the control group for both tests. 
 
Table (3): Sensitivity of XO and MDA tests 
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Discussion 
Xanthine oxidase is an important source of 
free radical generation. Under ischemic 
conditions, increased Ca2+ levels activates 
Ca2+ dependent proteases which cause 
selective proteolysis of the dehydrogenase to 
convert it into xanthine oxidase which acts 
both on hypoxanthine and xanthine at the 
expense of molecular oxygen to produce 
superoxide ion 10. 
In this study we found significant increase 
(p<0.05) in the activity of xanthine oxidase 
and the levels of MDA in the blood of 
patients with myocardial infarction compared 
to the control group indicating that 
myocardial ischemia has a definite correlation 
with xanthine oxidase activity and the levels 
of MDA and thus the measurement of 
xanthine oxidase activity may be used as a 
biochemical marker of myocardial infarction 
along with ECG. These findings were in 
agreement with those of Rashmi et al 11. 
As the marker of the ischemic myocardial 
syndrome, xanthine oxidase was shown to be 
better than MDA test. MDA in the blood of 
patients with myocardial may also be used but 
the sensitivity of MDA (88%) was less than 
that of xanthine oxidase (100%), also MDA 
showed increased levels in healthy persons 
(2%) while XO tests showed no elevation in 
the control group (0%). Moreover, the 
measurement of MDA levels is complicated 
and time consuming as compared to the assay 
of xanthine oxidase activity. Elsewhere XO 
and MDA tests were suggested to be the next 
generation of cardiac diseases markers12.  
In a previous study at 2002 troponin was 
found to rise following strenuous exercise and 
in obese persons in the absence of heart 
disease13. Pasquale et al 14 also reported that 
12.7% out of 102 patients with acute coronary 
syndromes were false negative for troponin 
results. It was reported that the troponin test 
reached a peak sensitivity of 96% and a 
specificity of 93% at 18 hours after symptom 
onset15. Thus, in comparison to these previous 
studies, the test of xanthine oxidase may be 
proposed as a useful biochemical marker of 
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